These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 31003196)

  • 1. Current status of small molecule drug development for Ebola virus and other filoviruses.
    Edwards MR; Basler CF
    Curr Opin Virol; 2019 Apr; 35():42-56. PubMed ID: 31003196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection.
    Isono M; Furuyama W; Kuroda M; Kondoh T; Igarashi M; Kajihara M; Yoshida R; Manzoor R; Okuya K; Miyamoto H; Feldmann H; Marzi A; Sakaitani M; Nanbo A; Takada A
    Antiviral Res; 2020 Nov; 183():104932. PubMed ID: 32946918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus Disease.
    Schafer A; Cheng H; Lee C; Du R; Han J; Perez J; Peet N; Manicassamy B; Rong L
    Curr Med Chem; 2018; 25(38):5177-5190. PubMed ID: 29032747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.
    Warren TK; Wells J; Panchal RG; Stuthman KS; Garza NL; Van Tongeren SA; Dong L; Retterer CJ; Eaton BP; Pegoraro G; Honnold S; Bantia S; Kotian P; Chen X; Taubenheim BR; Welch LS; Minning DM; Babu YS; Sheridan WP; Bavari S
    Nature; 2014 Apr; 508(7496):402-5. PubMed ID: 24590073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor.
    Cheng H; Schafer A; Soloveva V; Gharaibeh D; Kenny T; Retterer C; Zamani R; Bavari S; Peet NP; Rong L
    Antiviral Res; 2017 Sep; 145():24-32. PubMed ID: 28645623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle.
    Martin B; Canard B; Decroly E
    Antiviral Res; 2017 May; 141():48-61. PubMed ID: 28192094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of filovirus entry inhibitors targeting the endosomal receptor NPC1 binding site.
    Wang LL; Palermo N; Estrada L; Thompson C; Patten JJ; Anantpadma M; Davey RA; Xiang SH
    Antiviral Res; 2021 May; 189():105059. PubMed ID: 33705865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity.
    Wirchnianski AS; Wec AZ; Nyakatura EK; Herbert AS; Slough MM; Kuehne AI; Mittler E; Jangra RK; Teruya J; Dye JM; Lai JR; Chandran K
    Front Immunol; 2021; 12():729851. PubMed ID: 34721393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
    Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
    J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of a small-molecule inhibitor of filovirus infection.
    Warren TK; Warfield KL; Wells J; Enterlein S; Smith M; Ruthel G; Yunus AS; Kinch MS; Goldblatt M; Aman MJ; Bavari S
    Antimicrob Agents Chemother; 2010 May; 54(5):2152-9. PubMed ID: 20211898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures.
    Bennett RP; Finch CL; Postnikova EN; Stewart RA; Cai Y; Yu S; Liang J; Dyall J; Salter JD; Smith HC; Kuhn JH
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33396288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse genetics systems as tools for the development of novel therapies against filoviruses.
    Hoenen T; Feldmann H
    Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1253-63. PubMed ID: 25169588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment.
    Landeras-Bueno S; Oda SI; Norris MJ; Li Salie Z; Guenaga J; Wyatt RT; Saphire EO
    mBio; 2019 Jul; 10(4):. PubMed ID: 31337716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment-focused Ebola trials, supportive care and future of filovirus care.
    Keshtkar-Jahromi M; Martins KAO; Cardile AP; Reisler RB; Christopher GW; Bavari S
    Expert Rev Anti Infect Ther; 2018 Jan; 16(1):67-76. PubMed ID: 29210303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for distinct mechanisms of small molecule inhibitors of filovirus entry.
    Schafer A; Xiong R; Cooper L; Nowar R; Lee H; Li Y; Ramirez BE; Peet NP; Caffrey M; Thatcher GRJ; Saphire EO; Cheng H; Rong L
    PLoS Pathog; 2021 Feb; 17(2):e1009312. PubMed ID: 33539432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
    Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
    J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir.
    Comer JE; Escaffre O; Neef N; Brasel T; Juelich TL; Smith JK; Smith J; Kalveram B; Perez DD; Massey S; Zhang L; Freiberg AN
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30717492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retro-2 and its dihydroquinazolinone derivatives inhibit filovirus infection.
    Shtanko O; Sakurai Y; Reyes AN; Noël R; Cintrat JC; Gillet D; Barbier J; Davey RA
    Antiviral Res; 2018 Jan; 149():154-163. PubMed ID: 29175127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug targets in infections with Ebola and Marburg viruses.
    Gene OG; Julia BE; Vanessa MR; Victoria WJ; Thomas GW; Lisa HE
    Infect Disord Drug Targets; 2009 Apr; 9(2):191-200. PubMed ID: 19275706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Small Molecule Entry Inhibitors of Ebola Virus.
    Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.